Roles & Responsibilities of Chief Investigator AgreementChief Investigator Agreement • July 1st, 2020
The Chief Investigator (CI) and all members of the research team shall comply with all current regulations (as amended from time to time) applicable to the performance of the study including, but not limited to: Policy Framework for Health & Social Care or relevant Governance Framework The Principles of the World Medical Association Declaration of Helsinki Data Protection Act (1998/2018) General Data Protection Regulations (2018) ICH Good Clinical Practice Guidelines (1996) and Revision 2 (R2 2017) Human Tissue Act (2006) UK Medicines for Human Use (Clinical Trials) Regulations (2004) UK Medicines for Human Use (Clinical Trials) Amendment Regulations 2006, SI 2006/1928 The UK Medicines for Human Use (Clinical Trials) Amendment (No.2) Regulations 2006, SI 2006/2984 The Medicines for Human Use (Clinical Trials) and Blood Safety and Quality (Amendment) Regulations 2008, SI 2008/941 The Mental Capacity Act (2005) I confirm that I have read and understood my responsibilities as
Chief Investigator AgreementChief Investigator Agreement • August 20th, 2020
This is a formal agreement whereby the Sponsor (UHS) delegates responsibilities to the Chief Investigator (CI). This agreement ensures that the study named in this agreement is conducted in accordance with the applicable regulations, legislation and Trust Policies. This agreement forms a binding contract.
ContractChief Investigator Agreement • December 2nd, 2020
